Prestige Consumer Healthcare In (PBH) Financials
PBH Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 3.3 billion | 1.7 billion |
2023-09-30 | 3.3 billion | 1.8 billion |
2023-06-30 | 3.3 billion | 1.9 billion |
2023-03-31 | 3.4 billion | 1.9 billion |
PBH Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 69.5 million | 2.4 million |
2023-09-30 | 59.5 million | 3.7 million |
2023-06-30 | 46.6 million | 4.1 million |
2023-03-31 | 56.4 million | 2.6 million |
PBH Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 53.0 million |
2023-09-30 | 53.6 million |
2023-06-30 | 53.3 million |
2023-03-31 | -240.6 million |
PBH Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 63.6 million | - | 14.2 million |
2023-09-30 | 60.1 million | 1.3 billion | 16.5 million |
2023-06-30 | 54.6 million | 1.3 billion | 18.6 million |
2023-03-31 | 58.5 million | 1.3 billion | 21.3 million |
PBH Shares Outstanding
PBH Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 2.0 million | - | 26.0 million | 39.5 million |
2023-09-30 | 2.9 million | - | 26.0 million | 40.1 million |
2023-06-30 | 1.5 million | - | 27.7 million | 36.2 million |
2023-03-31 | 2.6 million | - | 27.7 million | 30.9 million |
PBH Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 282.7 million | 124.8 million |
2023-09-30 | 286.3 million | 126.3 million |
2023-06-30 | 279.3 million | 124.6 million |
2023-03-31 | 285.9 million | 132.1 million |
PBH
Price: $71.12
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.61 USD
P/E Ratio: -41.62
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 211300
Ebitda: 92.0 millionMarket Capitalization: 3.4 billion
Average Dividend Frequency: 1